Cargando…
Molecular characterization of para-aminosalicylic acid resistant Mycobacterium tuberculosis clinical isolates in southwestern China
PURPOSE: The aim of this study is to investigate para-aminosalicylic acid (PAS) resistance-related gene mutations in clinical Mycobacterium tuberculosis (MTB) isolates and analyze the associated risk factors in southwestern China. PATIENTS AND METHODS: Total 122 PAS-resistant and 55 PAS-susceptible...
Autores principales: | Luo, Ming, Li, Kun, Zhang, Huizheng, Yan, Xiaofeng, Gu, Jing, Zhang, Zhen, Chen, Yu, Li, Jungang, Wang, Jing, Chen, Yaokai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664864/ https://www.ncbi.nlm.nih.gov/pubmed/31440065 http://dx.doi.org/10.2147/IDR.S207259 |
Ejemplares similares
-
Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
por: Zhang, Tingting, et al.
Publicado: (2019) -
Analysis of mutations leading to para-aminosalicylic acid resistance in Mycobacterium tuberculosis
por: Pandey, Bharati, et al.
Publicado: (2019) -
Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to para-Aminosalicylic Acid in Mycobacterium tuberculosis
por: Yu, Ji-fang, et al.
Publicado: (2022) -
Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China
por: Li, Kun, et al.
Publicado: (2021) -
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
por: Zheng, Jun, et al.
Publicado: (2013)